Dec 12, 2023

Tafinlar Plus Mekinist Shows Benefits In Pediatric Glioma

A recent phase 2 trial revealed that the combination of Tafinlar and Mekinist benefitted children with BRAF-mutated low-grade gliomas.

Comentarios

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

Why copper could be key to treating a rare childhood cancer

Innovative surgery preserves limb growth for childhood bone cancer patients

CAR-T Cell Therapy Shows EFS Benefit in Pediatric Leukemia Subset

Global clinical trial shows improved survival rates for common childhood leukemia

More than half of children with cancer die in the hospital

A new CHOP research program is exploring ways to reduce long-term effects of cancer treatment

The ticking ‘epigenetic’ clock measures true biological age

Serum protein panel test can help identify cardiomyopathy risk in childhood cancer survivors

UCalgary researchers help preserve future fertility options for children impacted by cancer